Stem cell biologist @MSKCancerCenter studying human PSCs for modeling development & disease and for cell therapy. Opinions are my own and do not represent MSK.
Congratulations to Shuibing for her new leadership position as Chair of Molecular & Medical Pharmacology at UCLA.
The Tri-I stem cell community in NYC will miss you - but we are excited for you - and hope to continue collaborating on the next part of your scientific journey.
After 16 wonderful years @WCMSurgery , I’m deeply honored to share that I will join @UCLAHealth@dgsomucla as Chair of Molecular & Medical Pharmacology in March 2027. Excited for this new chapter of science, innovation, and collaboration!
Dr. @TabarViviane and Dr. @studerl, physician-scientists at MSK, have developed a treatment for #Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them into patients. Early results show the treatment is safe and may improve Parkinson’s symptoms.
"This is an important milestone on the road towards regenerative brain repair," says Dr. Tabar. "It represents more than two decades of collaborative work, based on very rigorous science beginning in our labs."
Learn more: https://t.co/QUOqYX0TRg https://t.co/VMG2nQtDR9
Congrats to @ZeltnerLab on their new paper. Genipin rescues developmental and degenerative defects in familial dysautonomia models and accelerates axon regeneration | Science Translational Medicine https://t.co/vhjSE8Qthf. It was exciting to see this story develop from way back.
👏 Congratulations to Dr. Deb Schrag, Chair of the @MSK_DeptOfMed, and Dr. @studerl, Director of the Center for Stem Cell Biology at MSK, who were elected to the @theNAMedicine, one of the highest honors bestowed upon scientists worldwide.
Learn more: https://t.co/N2NdRJv4TE
📢 Join us!
Developmental and stem cell biologists, checkout our tenure-track faculty position at Sloan Kettering.
Apply by October 18.
#DevBio#StemCell#hiringnow
https://t.co/9h9gl6EZEe
🥇 The top spot goes to Drs. Stefan Irion (@bigosi) and Viviane Tabar (@TabarViviane)! This episode was recorded live at @BlueRockTx and focuses on bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson’s disease! #InternationalPodcastDay
https://t.co/uY16FcaT7B
Congratulations to Dr. Shuibing Chen (@ChenShuibing) on her lab's new @CellStemCell paper!
Her team developed vascularized macrophage-islet #organoids to study damage from infection.
Read the article: https://t.co/3n4X8STm5p
Learn more about her work 👇 https://t.co/8lUmovVE2a
Exciting opportunity for open tenure track positions in Developmental Biology & Stem Cell Biology @MSKCancerCenter (see Ad - https://t.co/BxutHyvFn1). Deadline for applications is October 14, 2024 (https://t.co/8SJujIBPP0)
We have a postdoc opportunity to work on cell therapy for #Parkinson’s disease in a highly collaborative environment @MSKCancerCenter@MSKEducation
Apply at https://t.co/iyoCYczNaM
1) Just out @Nature today! We show that human TMEFF1 is a restriction factor for #Herpes simplex virus 1(HSV1) in the brain, by limiting NECTIN1—HSV1-gD mediated HSV1 entry into cortical neurons. TMEFF1 defect can underlie HSV1 #encephalitis. https://t.co/ESeorkXBGC
Excellent thread from @ShenYingZhang1 on this new collaborative story, and for our lab one of the first studies to test run new hindbrain neuron protocol developed by @harschnitz
(1) We are happy to share our new study, “SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency” @JExpMed! https://t.co/WIRWBLH9RJ. Accumulation of RNA lariats results in impaired antiviral immunity in hPSC-derived hindbrain neurons, underlying encephalitis. https://t.co/UI6M7bwnxt
Super excited to see this study finally published after many years of work. Congrats to @NatSaurat for the heroic effort and to all the many amazing collaborators who made this work possible. Also big thanks to our funders particularly the JPB foundation, NIA and @ASAP_Research.
How to trigger age-related features in hPSC neurons? In a CRISPR screen @NatSaurat identified neddylation inhibition as a tool to trigger hallmarks of aging in neurons and selective degeneration in AD or PD but not isogenic control neurons. @cellstemcell https://t.co/vycsfPED6g
How to trigger age-related features in hPSC neurons? In a CRISPR screen @NatSaurat identified neddylation inhibition as a tool to trigger hallmarks of aging in neurons and selective degeneration in AD or PD but not isogenic control neurons. @cellstemcell https://t.co/vycsfPED6g
Excited to share that my doctoral thesis work is out in @CellCellPress
We investigated a molecular driver to trigger hPSC-derived midbrain dopamine neurons during engraftment in mice.